<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318888</url>
  </required_header>
  <id_info>
    <org_study_id>Dnr 2009/123</org_study_id>
    <nct_id>NCT02318888</nct_id>
  </id_info>
  <brief_title>Does Icodextrin Reduce the Risk of Small Bowel Obstruction?</brief_title>
  <official_title>Does Icodextrin Reduce the Risk of Small Bowel Obstruction?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims at investigating if icodextrin 4% instilled in abdominal cavity during surgery
      can reduce the risk of surgery and hospitalisation for small bowel obstruction in patients
      with colorectal cancer. Follow-up data is collected from the Swedish national colorectal
      cancer registry.Patients are followed for 5 years postoperatively.The study is a randomized
      Swedish multicenter study and planned to include 1,800 patients. A safety control is planned
      after 300 included patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Icodextrin 7.5% is used in peritoneal dialysis. In animal models and in gynecological surgery
      a 4% solution of Icodextrin has been tested as a possible agent of reducing adhesions by
      acting as a barrier between peritoneal surfaces. Some data support a reduction af adhesions
      (van den Tool et al., Brown et al.). However, is not known whether icodextrin reduces the
      need for surgery or hospitalisation for small bowel obstruction.This study aims to study
      these parameters as well as complications and survival.

      Patients with colorectal cancer and scheduled for surgery with curative intent will be (after
      patients acceptance) randomized to have icodextrin 4% instilled in the abdominal cavity or
      not. Patients allocated to icodextrin arm will have 100 ml of icodextrin 4% instilled every
      30 minutes during surgery and at end of operation further 1000 ml instilled in the abdominal
      cavity. Postoperative care is performed according to each hospital praxis.

      Follow-up data will be collected from the Swedish National Colorectal cancer registry. Data
      30 days postoperatively will be analysed for early small bowel obstruction and other early
      complications. The study ends 5 years postoperatively with analysis of surgery and
      hospitalization for small bowel obstruction as well as survival and longterm complications.

      A safety analysis is planned after the first 300 randomized patients with respect to early
      (30 days) complications. These data will analysed blindly by external reviewers.

      Randomization (1:1) will be performed at the Regional Cancer Centrum in the Uppsala-Örebro
      region. The study aims to randomise 1800 patients.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2009</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgery for small bowel obstruction</measure>
    <time_frame>5 years</time_frame>
    <description>The proportion of patients that have undergone surgery for small bowel obstruction will be compared between the groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for small bowel obstruction</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall and cancer survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>Safety control of first 300 randomised patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>For all randomised patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1808</enrollment>
  <condition>Surgical Adhesions</condition>
  <arm_group>
    <arm_group_label>Surgery and Icodextrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Icodextrin 4% instilled every 30 minutes during surgery and 1000 ml instilled before closure of abdomen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No instillations during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <arm_group_label>Surgery and Icodextrin</arm_group_label>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Icodextrin</intervention_name>
    <arm_group_label>Surgery and Icodextrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Colorectal cancer

          -  Curative surgery planned

          -  Informed consent

          -  Age 18-85

        Exclusion Criteria:

          -  Local surgery planned

          -  Generalized disease

          -  Other malignancy

          -  Not informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urban Karlbom, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Uppsala</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars Påhlman, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eskilstuna Hospital</name>
      <address>
        <city>Eskilstuna</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Falun Hospital</name>
      <address>
        <city>Falun</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gävle Hospital</name>
      <address>
        <city>Gävle</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jönköping Hospital</name>
      <address>
        <city>Jönköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karlstad Hospital</name>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lidköping Hospital</name>
      <address>
        <city>Lidköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Luleå Hospital</name>
      <address>
        <city>Luleå</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mora Hospital</name>
      <address>
        <city>Mora</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norrrköping Hospital</name>
      <address>
        <city>Norrköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nyköping Hospital</name>
      <address>
        <city>Nyköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torsby Hospital</name>
      <address>
        <city>Torsby</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Västerås Hospital</name>
      <address>
        <city>Västerås</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>van den Tol P, ten Raa S, van Grevenstein H, Marquet R, van Eijck C, Jeekel H. Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis. Surgery. 2005 Mar;137(3):348-54.</citation>
    <PMID>15746791</PMID>
  </reference>
  <reference>
    <citation>Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS; Adept Adhesion Reduction Study Group. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril. 2007 Nov;88(5):1413-26. Epub 2007 Mar 26.</citation>
    <PMID>17383643</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Small bowel obstruction, Surgery, Colorectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Obstruction</mesh_term>
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Icodextrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

